NCT06360744View on ClinicalTrials.gov

A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

July 5, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
SARS CoV 2 Infection
Interventions
BIOLOGICAL

Johnson & Johnson

Vaccination with the Johnson \& Johnson vaccine which is NOT part of the Danish National Government programme

Trial Locations (5)

2600

Hvidovre Hospital, Hvidovre

4000

Sjællandsuniversitetshospital, Roskilde

5000

Odense Universitetshospital, Odense

8000

Aalborg Universitetshospital Syd, Aalborg

8200

Aarhus Universitetshospital, Skejby, Aarhus

All Listed Sponsors
collaborator

Ministry of the Interior and Health, Denmark

OTHER_GOV

lead

Jens D Lundgren, MD

OTHER